778451

Spectrum Pharmaceuticals, Inc. — FEI 3005383580

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 2, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)